Milan to Host International Conference on Gastrointestinal Cancer Research and Treatment

Milan, Italy, will be the site of a significant international conference, “ONCOGI 3.0 – An integrated cross-disciplinary approach to the Study and Treatment of gastrointestinal Tract Tumors,” on April 14, 2026. The event, organized by Elma Academy in collaboration with the National Cancer Institute of Milan, aims to foster collaboration and advance research in the complex field of gastrointestinal cancers.

Addressing the Complexity of GI Cancers

Cancers of the gastrointestinal (GI) tract are recognized for their biological and clinical complexity. Effective treatment requires a comprehensive approach integrating basic, translational, and clinical research to optimize patient outcomes. The ONCOGI 3.0 conference will focus on key areas to improve the research and treatment of these cancers.

Key Focus Areas of ONCOGI 3.0

• Role of Cooperative Groups: Exploring the benefits of collaborative research efforts.
• Multidisciplinarity: Highlighting the importance of diverse expertise in cancer care.
• National and International Collaborations: Strengthening partnerships to accelerate discovery.
• Academia-Industry Interaction: Facilitating the translation of research into clinical practice.
• Innovative Models of Clinical and Translational Research: Developing new approaches to improve treatment strategies.

A Platform for Non-Profit and Translational Research

Dr. Filippo Pietrantonio, a GI medical oncologist at the National Cancer Institute of Milan, emphasized the importance of the meeting as an opportunity to assess the progress of non-profit and translational clinical research. He highlighted the value of open discussion among colleagues from Italy and abroad to chart the future direction of the field. Source

Dr. Filippo Pietrantonio: A Leading Figure in Gastrointestinal Oncology

Dr. Pietrantonio is a medical oncologist and researcher affiliated with the Fondazione IRCCS Istituto Nazionale dei Tumori in Milan since 2007. His work centers on the study and treatment of gastrointestinal cancers, including those of the colon-rectum, stomach, esophagus, liver, biliary tract, pancreas, and peritoneum. Source He has authored over 350 scientific publications and leads numerous clinical trials, focusing on identifying biomarkers to predict treatment response. Source

Dr. Pietrantonio is also actively involved in organizations dedicated to advancing GI cancer research, including the Fondazione GONO Onlus and the Associazione Italiana di Oncologia Medica. Source He is also the Scientific Secretary at GONO. Source

Event Details and Registration

The ONCOGI 3.0 conference will be held in Milan on April 14, 2026. The event aims to consolidate advanced skills, promote an integrated research culture, and foster new collaborative synergies. Source Interested participants can enroll here.